Your browser doesn't support javascript.
loading
Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.
O'Brien, Thomas R; Thomas, David L; Jackson, Sarah S; Prokunina-Olsson, Ludmila; Donnelly, Raymond P; Hartmann, Rune.
Afiliação
  • O'Brien TR; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Thomas DL; Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
  • Jackson SS; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Prokunina-Olsson L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Donnelly RP; Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Hartmann R; Department of Molecular Biology and Genetics, University of Aarhus, Aarhus, Denmark.
Clin Infect Dis ; 71(6): 1410-1412, 2020 09 12.
Article em En | MEDLINE | ID: mdl-32301957
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Interferon gama / Infecções por Coronavirus / Betacoronavirus Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Interferon gama / Infecções por Coronavirus / Betacoronavirus Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article